How Gilson is helping biotech's scale-up peptide purification for drug discovery

In this case study, Gilson is highlighted for its pivotal role in assisting the Institute for Research and Innovation in Biomedicine (IRIB) in Rouen, France. The IRIB, focusing on innovative technologies for disease diagnosis and treatment, collaborates across multidisciplinary fields like biology, chemistry, physics, and medicine. Benjamin Lefranc, an Inserm Research Engineer at IRIB, specifically utilizes Gilson’s high-performance liquid chromatography (HPLC) systems to manage the peptide synthesis service. Peptides are vital in drug discovery but pose challenges in purification due to their complexity and sensitivity. Gilson’s HPLC systems have been instrumental for IRIB researchers in overcoming these purification challenges.